Rocket Doctor AI Grants Equity
Analysis based on 6 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The equity grant is a routine corporate action with minimal direct market impact, potentially signaling confidence in the company's growth prospects. It may slightly dilute existing shareholders but is unlikely to significantly affect the stock price.
Rocket Doctor AI, Inc. announced on August 24, 2026 that it granted an aggregate of 24,000 stock options exercisable at $0.70 per share for a three-year term, and 276,053 restricted share units with terms of one to three years, to consultants of the company and its subsidiary. The grants are issued under the company's share compensation plans, with 96,000 restricted share units and all stock options subject to one-year vesting. All securities are subject to a four-month-and-one-day hold period per Canadian Securities Exchange policies. Rocket Doctor AI, Inc. is a Vancouver-based company providing AI-powered healthcare solutions, including the Global Library of Medicine and the Rocket Doctor AI, Inc. digital health platform.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard